Ogilvie, Kathleen M.

RAR and RXR modulation in cancer and metabolic disease

Altucci, L., Leibowitz, M. D., Ogilvie, K. M., de Lera, A. R., & Gronemeyer, H. (2007) · Nature Reviews Drug Discovery

Retinoids in leukemia and cellular processesPeroxisome Proliferator-Activated Receptors

Cited by 517

Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody

Huang, J., Ishino, T., Chen, G., Rolzin, P., Osothprarop, T. F., Retting, K., Li, L., Jin, P., Matin, M. J., Huyghe, B., et al. (2013) · The Journal of Pharmacology and Experimental Therapeutics

Fibroblast Growth Factor ResearchMonoclonal and Polyclonal Antibodies Research

Cited by 121

Metabolic Effects of Rexinoids: Tissue-Specific Regulation of Lipoprotein Lipase Activity

Davies, P. J. A., Berry, S. A., Shipley, G. L., Eckel, R. H., Hennuyer, N., Crombie, D. L., Ogilvie, K. M., Peinado-Onsurbe, J., Fievet, C., Leibowitz, M. D., et al. (2001) · Molecular Pharmacology

Lipid metabolism and disordersPeroxisome Proliferator-Activated Receptors

Cited by 89